Summary
Socure has 2 registry-verified rows in the CertReports index, last verified 17 Sep 2026. The strongest row is FedRAMP: FedRAMP Authorized. This page is independent of the vendor’s own trust centre: dates, sources and caveats come from CertReports captures.
Reviewer brief
As of 17 Sep 2026, Socure (socure.com) is listed in the FedRAMP registry as FedRAMP Authorized, with the authorization issued on 19 Mar 2025 and audited by Kratos. As of 17 Sep 2026, Socure is listed in the EU-US Data Privacy Framework registry as having Active EU-US Certification, UK Extension Certification, and SW-US Certification, originally issued 07 Dec 2016 and set to expire 25 Sep 2026. As of 17 Sep 2026, no public evidence found for a SOC 2 Type II report for Socure. As of 17 Sep 2026, no public evidence found for a BAA offering (HIPAA) for Socure. As of 17 Sep 2026, no subprocessor information was found in the evidence rows for Socure.
- FedRAMP: listed in FedRAMP registry as FedRAMP Authorized, issued 19 Mar 2025, audited by Kratos (as of 17 Sep 2026)
- EU-US Data Privacy Framework: listed in DPF registry as Active (EU-US, UK Extension, SW-US Certifications), issued 07 Dec 2016, expiring 25 Sep 2026 (as of 17 Sep 2026)
- SOC 2 and HIPAA: no public evidence found for either framework as of 17 Sep 2026
Facts only, each dated; nothing here is inferred, scored or advised. Brief generated 17 Sep 2026; it is regenerated whenever a row changes.
Among identity and access vendors
2verified rows
Category median 1, across 47 indexed identity and access vendors. Socure has more verified rows than 96 percent of them.
ai verificationcomplianceidentity verificationkyc
Compare with similar vendors
Pick your own comparisonCompliance grid
Legal artefacts
No DPA, BAA or subprocessor list has been captured from a public page yet. Registry rows above do not depend on this. Check the vendor trust centre.
Subprocessors
No subprocessor list captured yet.
Similar vendors with evidence
Related by product tags and the Identity and access category, ranked by shared tags, description similarity and overlapping evidence. Never by popularity.
